Compare · HCXY vs PAND
HCXY vs PAND
Side-by-side comparison of Hercules Capital, Inc. (HCXY) and Pandion Therapeutics Inc. (PAND): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HCXY and PAND operate in n/a (n/a), so they compete in similar markets.
- HCXY carries a market cap of $4.52B.
Latest HCXY
- Hercules Capital Announces Date of 2026 Annual Meeting of Stockholders
- Hercules Capital Reports First Quarter 2026 Financial Results
- Hercules Capital Enters Next Phase of Growth with Expanded Leadership Team
- Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the First Quarter 2026
- Hercules Capital Announces Date for Release of First Quarter 2026 Financial Results and Conference Call
- Hercules Capital Sets New Record with All-Time High New Debt and Equity Commitments
- Hercules Capital Receives a BBB (high) Affirmed Investment Grade Corporate and Credit Rating from Morningstar DBRS
- Hercules Capital Named 2025 Americas BDC Manager of the Year by Private Debt Investor
- Hercules Capital Reports Fourth Quarter and Full-Year 2025 Financial Results
- Hercules Capital Closes Institutional Notes Offering of $300.0 Million 5.350% Unsecured Notes due 2029
Latest PAND
- SEC Form SC 13G/A filed by Pandion Therapeutics Inc. (Amendment)
- SEC Form 15-12B filed by Pandion Therapeutics Inc.
- SEC Form SC 13D/A filed by Pandion Therapeutics Inc. (Amendment)
- SEC Form EFFECT filed by Pandion Therapeutics Inc.
- SEC Form EFFECT filed by Pandion Therapeutics Inc.
- SEC Form SC 13D/A filed by Pandion Therapeutics Inc. (Amendment)
- SEC Form 4: L. Joanne Viney decreased direct ownership by 100% to 0 units
- SEC Form 4: Vikas Goyal decreased direct ownership by 100% to 0 units
- SEC Form 4: L Alan Crane decreased direct ownership by 100% to 0 units
- SEC Form 4: D. Edward Freedman decreased direct ownership by 100% to 0 units